RxDoctor Payments Data

Ralph Bowers, MD

Family Medicine · la Fayette, GANPI 1700820198

Payments from drug & device makers

$150in general payments, 2019–2025

Across 9 payments — averaging $16.61 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Merck$38
  • Sanofi-aventis U.S. LLC$38
  • Pfizer$18
  • Esperion Therapeutics, Inc.$15
  • E.r. Squibb & Sons, L.L.C.$14
  • Sanofi Pasteur Inc.$13
  • plus $13 from 1 others

What the payments were for

  • Food & beverage$150100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
22

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$150 in reported general payments places this provider in the 25th percentile of 3,111 family medicine providers in Georgia.

See all family medicine providers in Georgia

Medicare billing

Part B allowed, 2024
$263,846
Medicare patients
545
Services billed
5,556

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide97$145,060
EliquisApixaban106$87,269
TrulicityDulaglutide58$77,898
MounjaroTirzepatide22$39,360
JardianceEmpagliflozin26$34,474
TradjentaLinagliptin19$28,008
RybelsusSemaglutide14$23,540
XareltoRivaroxaban13$20,553
FarxigaDapagliflozin Propanediol14$20,266
JanuviaSitagliptin Phosphate12$13,094
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog29$12,406
Lantus SolostarInsulin Glargine,hum.Rec.Anlog40$10,982
EntrestoSacubitril/Valsartan16$10,689
MyrbetriqMirabegron11$7,630
Pyridostigmine Bromide ErPyridostigmine Bromide11$7,048

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Rybelsus$13$168,600111 claims
PfizerEliquis$18$87,269106 claims
MerckJanuvia$38$13,09412 claims
Sanofi-aventis U.S. LLCLantus$38$6,50529 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 25th percentile of 3,111 family medicine providers in Georgia.

Other family medicine in la Fayette

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →